Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-04

Clinical Trial Update: Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating efficacy and safety of Micafungin for Injection to prevent and treat fungal infections in patients with hematological tumors a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micafungin for Injection (micafungin)

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease | Phase 4 | Status: UNKNOWN